Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

AXGN

Axogen Inc

Jun 18 • 04:00PM ET

9.29

Dollar change -0.24
Percentage change -2.52	%

Healthcare • Medical Devices • USA • NASD

Peers: IART BAX SYK ZBH MDT JNJ GMED EW PODD HOLX

| Held by: VTI IWM VXF IWO VTWO IHI FESM SCHA DWAS PTH

Index	RUT	P/E	-	EPS (ttm)	-0.16	Insider Own	5.54%	Shs Outstand	45.51M	Perf Week	-8.65%
Market Cap	423.10M	Forward P/E	19.56	EPS next Y	0.47	Insider Trans	-3.59%	Shs Float	43.02M	Perf Month	-21.00%
Income	-7.16M	PEG	-	EPS next Q	0.06	Inst Own	86.27%	Short Float	4.76%	Perf Quarter	-48.10%
Sales	194.52M	P/S	2.18	EPS this Y	60.71%	Inst Trans	8.86%	Short Ratio	3.47	Perf Half Y	-34.39%
Book/sh	2.32	P/B	4.01	EPS next Y	127.35%	ROA	-3.74%	Short Interest	2.05M	Perf Year	21.60%
Cash/sh	0.62	P/C	15.07	EPS next 5Y	86.26%	ROE	-7.22%	52W Range	6.59 - 21.00	Perf YTD	-43.63%
Dividend Est.	-	P/FCF	355.55	EPS past 5Y	21.24%	ROIC	-4.17%	52W High	-55.76%	Beta	1.06
Dividend TTM	-	Quick Ratio	2.65	Sales past 5Y	11.91%	Gross Margin	74.18%	52W Low	40.97%	ATR (14)	0.59
Dividend Ex-Date	Jan 27, 2010	Current Ratio	4.28	EPS Y/Y TTM	67.41%	Oper. Margin	-0.25%	RSI (14)	24.38	Volatility	1.32% 2.49%
Employees	452	Debt/Eq	0.65	Sales Y/Y TTM	18.81%	Profit Margin	-3.68%	Recom	1.12	Target Price	24.25
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	44.76%	Payout	-	Rel Volume	0.94	Prev Close	9.53
Sales Surprise	0.53%	EPS Surprise	-236.99%	Sales Q/Q	17.36%	Earnings	May 08 BMO	Avg Volume	590.22K	Price	9.29
SMA20	-12.37%	SMA50	-29.10%	SMA200	-38.44%	Trades		Volume	553,430	Change	-2.52%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-17-25	Initiated	Lake Street	Buy	$30
Jul-01-24	Initiated	Raymond James	Outperform	$13
Nov-11-22	Resumed	Jefferies	Buy	$15
May-09-22	Upgrade	Canaccord Genuity	Hold → Buy	$10 → $15
Mar-11-22	Resumed	Cantor Fitzgerald	Overweight	$21
Oct-23-20	Initiated	Guggenheim	Buy	$24
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$16
May-07-20	Downgrade	Canaccord Genuity	Buy → Hold	$12
Apr-02-20	Downgrade	BTIG Research	Buy → Neutral
Aug-07-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-12-19	Initiated	Canaccord Genuity	Buy	$32
Mar-02-18	Reiterated	Lake Street	Buy	$26 → $38
Jan-05-18	Resumed	Cantor Fitzgerald	Overweight
Nov-30-17	Initiated	Jefferies	Buy	$35
Nov-21-17	Reiterated	Lake Street	Buy	$22 → $26
Jul-31-17	Initiated	Leerink Partners	Outperform	$22
Jun-30-17	Initiated	Cantor Fitzgerald	Overweight	$18
Mar-06-17	Initiated	ROTH Capital	Buy	$14.50
Nov-22-16	Upgrade	Lake Street	Hold → Buy	$9 → $11
Nov-07-16	Reiterated	Wedbush	Outperform	$10 → $12

Show Previous Ratings

May-28-25 08:00AM	Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference (GlobeNewswire)
May-21-25 09:35AM	AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-09-25 09:45AM	Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline (Zacks) -9.73%
09:30AM	MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off (Zacks)
03:08AM	Axogen Inc (AXGN) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Progress Amid ... (GuruFocus.com)
08:30AM	Loading…
May-08-25 08:30AM	AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -23.18%
07:28AM	AxoGen: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Axogen, Inc. Reports 2025 First Quarter Financial Results (GlobeNewswire)
07:00AM	Axogen Announces Chief Financial Officer Transition (GlobeNewswire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
01:09PM	COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised (Zacks)
12:31PM	AxoGen Q1 2025 Earnings Preview (Seeking Alpha)
May-02-25 01:22PM	SYK Stock Falls Despite Q1 Earnings & Sales Beat on Lower '25 EPS View (Zacks)
01:21PM	DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins (Zacks)
Apr-24-25 08:04AM	Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 (GlobeNewswire)
03:03PM	Loading…
Mar-31-25 03:03PM	Stryker Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Mar-25-25 11:12AM	Axogen: LT Bullish, But Outcomes Weighted To Downside, At This Point (SeekingAlpha)
Mar-24-25 08:00AM	Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-04-25 03:04PM	Alcon Stock Gets Relative Strength Rating Lift (Investor's Business Daily)
Feb-26-25 02:03AM	Axogen Inc (AXGN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Market ... (GuruFocus.com)
12:27AM	Q4 2024 AxoGen Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-25-25 07:41AM	AxoGen: Q4 Earnings Snapshot (Associated Press Finance) +11.66%
07:10AM	Axogen, Inc. To Host Analyst & Investor Day on March 4th (GlobeNewswire)
07:00AM	Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results (GlobeNewswire)
Feb-11-25 04:58PM	Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 (GlobeNewswire)
Feb-03-25 08:00AM	Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-13-25 09:35AM	AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? (Zacks)
05:05AM	AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? (Zacks)
Jan-10-25 05:00PM	Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +18.21%
08:00AM	Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024 (GlobeNewswire)
09:15AM	Loading…
Dec-24-24 09:15AM	AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? (Zacks) -5.41%
Dec-19-24 09:40AM	Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Nov-28-24 12:00PM	All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy (Zacks)
Nov-25-24 09:55AM	How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18% (Zacks)
Nov-08-24 07:35AM	AxoGen Reports Strong Q3 2024 Revenue Growth (TipRanks)
02:08AM	Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
Nov-07-24 07:48AM	AxoGen: Q3 Earnings Snapshot (Associated Press Finance) -13.44%
07:00AM	Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update (GlobeNewswire)
Oct-24-24 07:00AM	Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 (GlobeNewswire)
Oct-14-24 07:21AM	AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? (Zacks)
Oct-09-24 05:30PM	Axogen Inc (AXGN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Sep-12-24 01:30AM	ArrowMark Colorado Holdings LLC Reduces Stake in Axogen Inc (GuruFocus.com)
Sep-06-24 07:00AM	Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft (GlobeNewswire)
Sep-04-24 09:15AM	AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? (Zacks)
Sep-03-24 07:00AM	Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4) (GlobeNewswire)
Aug-30-24 12:00PM	What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now? (Zacks)
Aug-23-24 09:55AM	Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High? (Zacks)
Aug-19-24 09:15AM	AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-13-24 04:18PM	CytoSorbents Appoints Peter J. Mariani Chief Financial Officer (GlobeNewswire)
Aug-09-24 12:56AM	Axogen names ex-Abbott exec Michael Dale as CEO (MedTech Dive)
Aug-08-24 08:20AM	AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates (Zacks) +35.10%
07:19AM	AxoGen: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Axogen, Inc. Announces New Leadership Appointments (GlobeNewswire)
07:00AM	Axogen, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-01-24 10:01AM	AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) -7.06%
Jul-23-24 07:00AM	Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 (GlobeNewswire)
Jul-12-24 08:37AM	AxoGen (AXGN) Soars 8.2%: Is Further Upside Left in the Stock? (Zacks)
Jul-01-24 07:00AM	Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) +6.49%
Jun-25-24 12:52PM	AxoGen's (AXGN) New Launch to Aid Peripheral Nerve Protection (Zacks)
Jun-24-24 07:00AM	Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix (GlobeNewswire)
Jun-12-24 04:56AM	Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength? (Zacks) +9.21%
May-28-24 04:30PM	Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia (GlobeNewswire) +5.90%
May-17-24 12:29PM	AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft (Zacks)
May-16-24 02:56PM	AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft (MT Newswires)
07:00AM	Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft (GlobeNewswire)
May-14-24 07:00AM	Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference (GlobeNewswire)
May-06-24 10:31AM	AxoGen, Inc. (NASDAQ:AXGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-03-24 03:02AM	Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges (GuruFocus.com)
May-02-24 11:57AM	AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) -10.37%
08:15AM	AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:14AM	AxoGen: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Axogen, Inc Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-29-24 04:50PM	Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix (GlobeNewswire)
Apr-16-24 07:00AM	Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 (GlobeNewswire)
Mar-08-24 11:55PM	Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) (GuruFocus.com)
Mar-06-24 08:20AM	AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-05-24 09:27PM	Q4 2023 AxoGen Inc Earnings Call (Thomson Reuters StreetEvents) -15.11%
11:53AM	AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
07:38AM	AxoGen: Q4 Earnings Snapshot (Associated Press Finance)
07:31AM	Axogen Inc (AXGN) Reports Growth in Revenue and Reduction in Net Loss for Q4 and Full-Year 2023 (GuruFocus.com)
07:00AM	Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results (GlobeNewswire)
Feb-28-24 08:50AM	AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Feb-26-24 09:15AM	AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue? (Zacks)
Feb-13-24 04:30PM	Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 (GlobeNewswire)
Feb-12-24 08:50AM	Here's Why Momentum in AxoGen (AXGN) Should Keep going (Zacks)
Feb-06-24 09:40AM	Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Feb-02-24 04:15PM	Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Jan-26-24 08:50AM	Here's What Could Help AxoGen (AXGN) Maintain Its Recent Price Strength (Zacks)
Jan-18-24 05:00PM	Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap (GlobeNewswire) +7.86%
Jan-04-24 04:45PM	Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 (GlobeNewswire) +26.67%
04:40PM	Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 (GlobeNewswire)
04:35PM	Axogen Announces Promotions on Research and Development Team (GlobeNewswire)
Dec-26-23 04:15PM	Axogen, Inc. Appoints Kathy Weiler to its Board of Directors (GlobeNewswire)
Dec-06-23 07:00AM	Axogen Announces Transition of Finance Team Leadership (GlobeNewswire) +5.19%
Dec-01-23 05:00PM	Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.04%
Nov-20-23 07:00AM	Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-08-23 09:41AM	AxoGen, Inc. (NASDAQ:AXGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 11:01PM	Q3 2023 AxoGen Inc Earnings Call (Thomson Reuters StreetEvents) +36.90%
08:04AM	Axogen Inc (AXGN) Reports 12% Revenue Growth in Q3 2023 (GuruFocus.com)
07:15AM	AxoGen: Q3 Earnings Snapshot (Associated Press Finance)

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weiler Kathy Johnson	Director	Jun 09 '25	Sale	10.61	4,073	43,215	6,580	Jun 11 04:27 PM
Levine Alan M	Director	Jun 09 '25	Sale	10.61	4,073	43,215	36,743	Jun 11 04:26 PM
Wendell Amy McBride	Director	Jun 09 '25	Sale	10.61	4,073	43,215	93,826	Jun 11 04:26 PM
Burke William P. Mr.	Director	Jun 09 '25	Sale	10.61	4,073	43,215	24,484	Jun 11 04:25 PM
NEELS GUIDO J	Director	Jun 09 '25	Sale	10.61	4,073	43,215	86,743	Jun 11 04:24 PM
JOHNSON JOHN	Director	Jun 09 '25	Sale	10.61	4,073	43,215	24,943	Jun 11 04:23 PM
TYNDALL JOSEPH A.	Director	Jun 10 '25	Option Exercise	6.56	11,586	75,952	26,931	Jun 11 04:22 PM
TYNDALL JOSEPH A.	Director	Jun 10 '25	Sale	10.72	26,931	288,700	0	Jun 11 04:22 PM
JOSEPH A TYNDALL	Director	Jun 10 '25	Proposed Sale	10.72	26,931	288,814		Jun 10 05:41 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Option Exercise	6.30	12,850	80,955	35,407	May 23 04:32 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Sale	11.20	20,062	224,694	15,345	May 23 04:32 PM
TYNDALL JOSEPH A.	Director	May 19 '25	Sale	11.63	2,525	29,366	22,557	May 23 04:12 PM
TYNDALL JOSEPH A.	Director	May 22 '25	Proposed Sale	11.15	32,339	360,580		May 22 05:14 PM
DeVinney Erick Wayne	Chief Innovation Officer	Mar 16 '25	Option Exercise	0.00	32,462	0	232,873	Mar 19 05:24 PM
DeVinney Erick Wayne	Chief Innovation Officer	Mar 19 '25	Sale	17.50	15,111	264,442	217,762	Mar 19 05:24 PM
Began Marc A	EVP & General Counsel	Mar 01 '25	Option Exercise	0.00	22,500	0	24,186	Mar 05 06:24 PM
Wendell Amy McBride	Director	Mar 03 '25	Sale	20.02	5,000	100,100	97,899	Mar 05 06:20 PM
DeVinney Erick Wayne	Chief Innovation Officer	Feb 28 '25	Option Exercise	0.00	24,799	0	209,301	Mar 04 07:22 PM
AMY MCBRIDE-WENDELL	Director	Mar 03 '25	Proposed Sale	20.01	5,000	100,050		Mar 03 04:16 PM
Kemp Jens	Chief Marketing Officer	Feb 22 '25	Option Exercise	0.00	2,500	0	2,500	Feb 26 04:25 PM
Zaderej Karen L.	SENIOR ADVISOR	Jan 21 '25	Proposed Sale	18.41	220,000	4,050,000		Jan 21 01:20 PM
Zaderej Karen L.	SENIOR ADVISOR	Jan 14 '25	Proposed Sale	18.00	100,000	1,800,000		Jan 14 01:24 PM
Zaderej Karen L.	SENIOR ADVISOR	Nov 07 '24	Proposed Sale	12.71	70,000	890,000		Nov 07 10:52 AM
Zaderej Karen L.	SENIOR ADVISOR	Sep 05 '24	Proposed Sale	13.00	150,000	1,950,000		Sep 05 04:33 PM
JOHNSON JOHN	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	29,016	Sep 04 09:13 PM
NEELS GUIDO J	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	90,816	Sep 04 09:11 PM
Levine Alan M	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	40,816	Sep 04 08:58 PM
Burke William P. Mr.	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	28,557	Sep 04 08:52 PM
THOMAS PAUL	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	32,052	Sep 04 08:33 PM
TYNDALL JOSEPH A.	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	22,557	Sep 04 07:52 PM
Wendell Amy McBride	Director	Sep 01 '24	Option Exercise	0.00	11,904	0	102,899	Sep 04 05:18 PM
Donovan Michael Patrick	Officer	Aug 21 '24	Proposed Sale	12.42	28,003	347,810		Aug 21 04:31 PM
GREG FREITAG	Director	Aug 13 '24	Proposed Sale	11.17	15,000	167,520		Aug 13 05:00 PM
Zaderej Karen L.	SENIOR ADVISOR	Aug 12 '24	Proposed Sale	10.00	200,000	2,000,000		Aug 12 10:59 AM

Dollar change +0.12
Percentage change 1.79	%

AMWL American Well Corporation daily Stock Chart

Peers: TDOC GDRX DOCS OMCL HIMS CLOV EHTH GH MOH CNC

| Held by: VTI VXF VHT PRFZ DFAT AVSC DFAS DFAC DXUV

Index	-	P/E	-	EPS (ttm)	-10.19	Insider Own	25.79%	Shs Outstand	14.14M	Perf Week	-5.15%
Market Cap	107.66M	Forward P/E	-	EPS next Y	-5.10	Insider Trans	-0.32%	Shs Float	11.73M	Perf Month	-6.58%
Income	-154.74M	PEG	-	EPS next Q	-1.80	Inst Own	39.03%	Short Float	1.95%	Perf Quarter	-14.12%
Sales	261.68M	P/S	0.41	EPS this Y	52.27%	Inst Trans	-0.04%	Short Ratio	4.66	Perf Half Y	-26.77%
Book/sh	18.62	P/B	0.37	EPS next Y	22.95%	ROA	-31.98%	Short Interest	0.23M	Perf Year	-13.00%
Cash/sh	14.07	P/C	0.48	EPS next 5Y	38.18%	ROE	-44.04%	52W Range	5.00 - 12.95	Perf YTD	-6.07%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-12.84%	ROIC	-52.01%	52W High	-47.41%	Beta	1.19
Dividend TTM	-	Quick Ratio	2.87	Sales past 5Y	11.31%	Gross Margin	31.84%	52W Low	36.20%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	2.89	EPS Y/Y TTM	58.22%	Oper. Margin	-60.08%	RSI (14)	44.97	Volatility	3.82% 2.77%
Employees	877	Debt/Eq	0.02	Sales Y/Y TTM	2.79%	Profit Margin	-59.14%	Recom	2.80	Target Price	10.25
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	75.85%	Payout	-	Rel Volume	0.36	Prev Close	6.69
Sales Surprise	11.10%	EPS Surprise	56.98%	Sales Q/Q	12.28%	Earnings	May 01 AMC	Avg Volume	49.25K	Price	6.81
SMA20	-2.85%	SMA50	-4.42%	SMA200	-21.38%	Trades		Volume	17,928	Change	1.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$15
Aug-03-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$5 → $2.50
Mar-23-23	Downgrade	TD Cowen	Outperform → Market Perform	$5 → $2.50
Feb-27-23	Downgrade	Piper Sandler	Overweight → Neutral	$5 → $3.50
Jan-04-23	Upgrade	BofA Securities	Neutral → Buy	$4.20
Sep-07-22	Initiated	Truist	Hold	$5
Apr-14-22	Initiated	Guggenheim	Buy	$6
Apr-01-22	Resumed	Credit Suisse	Neutral	$5
Feb-11-22	Initiated	Goldman	Neutral	$6
Dec-02-21	Initiated	Jefferies	Hold	$6
Oct-19-21	Initiated	Wells Fargo	Equal Weight	$8
Sep-14-21	Initiated	Cantor Fitzgerald	Overweight	$15
May-17-21	Upgrade	Guggenheim	Neutral → Buy	$15
Apr-16-21	Initiated	KeyBanc Capital Markets	Sector Weight
Apr-15-21	Initiated	Needham	Hold
Jan-28-21	Downgrade	Credit Suisse	Outperform → Neutral	$41
Jan-07-21	Initiated	BTIG Research	Neutral
Dec-18-20	Initiated	Stifel	Hold	$29
Nov-18-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$26
Oct-23-20	Initiated	Guggenheim	Neutral

Show Previous Ratings

Jun-05-25 12:20PM	HIMS' Buyouts Fuel International Expansion & Digital Health Innovation (Zacks)
Jun-04-25 12:10PM	Top Stock Movers Now: DR Horton, Wells Fargo, Dollar Tree, and More (Investopedia)
May-30-25 12:21PM	Hims & Hers vs. Amwell: Which Telehealth Stock Is the Better Buy? (Zacks)
May-06-25 04:05PM	Amwell makes grant to new employee under inducement plan (GlobeNewswire) -7.11%
12:00PM	All You Need to Know About American Well (AMWL) Rating Upgrade to Buy (Zacks)
09:55AM	Loading…
09:55AM	Does American Well (AMWL) Have the Potential to Rally 46.51% as Wall Street Analysts Expect? (Zacks)
09:40AM	Is American Well (AMWL) Outperforming Other Medical Stocks This Year? (Zacks)
May-02-25 10:05AM	Amwell narrows losses in Q1 amid military contract rollout (Healthcare Dive) +19.71%
03:20AM	American Well Corp (AMWL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-01-25 08:05PM	American Well Corporation (AMWL) Q1 2025 Earnings Call Transcript (Seeking Alpha) -15.55%
07:00PM	American Well (AMWL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:25PM	American Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for First Quarter 2025 (GlobeNewswire)
Apr-24-25 07:30AM	Amwell to participate in upcoming investor conferences (GlobeNewswire)
Apr-17-25 07:05AM	Amwell to report first quarter 2025 operating results (GlobeNewswire)
04:05PM	Loading…
Mar-03-25 04:05PM	Amwell makes inducement grant (GlobeNewswire) -12.15%
08:05AM	Amwell announces innovation leader as chief product and technology officer (GlobeNewswire)
05:12AM	Amwell names Amazon vet to chief product and technology role (Healthcare Dive)
Feb-21-25 09:22AM	Amwell makes grants to new employees under inducement plan (GlobeNewswire)
Feb-19-25 04:05PM	Amwell to participate in upcoming investor conference (GlobeNewswire)
Feb-13-25 10:58AM	Q4 2024 American Well Corp Earnings Call (Thomson Reuters StreetEvents) -5.02%
03:54AM	Amwell touts military contract deployment wins in Q4 (Healthcare Dive)
02:17AM	American Well Corp (AMWL) Q4 2024 Earnings Call Highlights: Strategic Gains Amidst Revenue ... (GuruFocus.com)
Feb-12-25 11:00PM	American Well (AMWL) Q4 2024 Earnings Call Transcript (Motley Fool) +7.67%
07:30PM	Compared to Estimates, American Well (AMWL) Q4 Earnings: A Look at Key Metrics (Zacks)
05:35PM	American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Feb-11-25 09:15AM	American Well (AMWL) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Jan-29-25 07:00AM	Amwell to report fourth quarter and full year 2024 operating results (GlobeNewswire)
Jan-15-25 08:05AM	Amwell adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care (GlobeNewswire) +5.64%
06:08AM	Loading…
Jan-14-25 06:08AM	Strength Seen in American Well (AMWL): Can Its 18.8% Jump Turn into More Strength? (Zacks) -6.99%
Jan-10-25 08:10AM	Amwell divests virtual psychiatric care business for $21M and added earn-out (TipRanks)
Jan-09-25 12:18PM	Amwell divests virtual psychiatric care business for $21m to boost cash flow (Medical Device Network)
09:11AM	Amwell sells virtual psychiatric care business to Avel eCare for $21M (Healthcare Dive)
08:12AM	Avel eCare Announces Acquisition of Amwell Psychiatric Care to Expand Telemedicine Services (ACCESS Newswire)
08:00AM	Amwell divests virtual psychiatric care business to Avel eCare in all-cash transaction (GlobeNewswire)
Dec-18-24 04:30PM	Amwell CFO Mark Hirschhorn Expands Leadership Role (GlobeNewswire) -6.98%
Nov-04-24 04:05PM	Amwell Makes Grants to New Employees Under Inducement Plan (GlobeNewswire)
Oct-31-24 05:00AM	American Well Corp (AMWL) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com) -5.08%
02:00AM	American Well (AMWL) Q3 2024 Earnings Call Transcript (Motley Fool)
Oct-30-24 08:00PM	American Well (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:55PM	American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Third Quarter 2024 (GlobeNewswire)
Oct-29-24 09:17AM	American Well Corp (AMWL) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-28-24 07:00AM	Amwell to participate in upcoming investor conferences (GlobeNewswire) +5.53%
Oct-23-24 10:01AM	American Well Corporation (AMWL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-16-24 05:18AM	Amwell taps ex-Teladoc exec as CFO (Healthcare Dive)
Oct-15-24 04:30PM	Amwell announces new chief financial officer (GlobeNewswire)
07:05AM	Amwell to report third quarter 2024 operating results (GlobeNewswire)
Oct-08-24 07:05AM	Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution (GlobeNewswire)
Aug-22-24 04:05PM	Amwell to Participate in Upcoming Investor Conferences (GlobeNewswire) +7.38%
Aug-05-24 03:33PM	3 Telemedicine Stocks Poised for Possible Healthcare Evolution (InvestorPlace) -13.48%
Aug-01-24 10:26AM	Amwell boosts 2024 adjusted earnings outlook, narrows net loss in Q2 (Healthcare Dive) +40.20%
12:45AM	American Well (AMWL) Q2 2024 Earnings Call Transcript (Motley Fool)
Jul-31-24 09:56PM	AMWL Stock Earnings: American Well Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
07:30PM	American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:25PM	American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Amwell Announces Results for Second Quarter 2024 (GlobeNewswire)
Jul-24-24 10:01AM	Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.65%
Jul-17-24 07:00AM	Amwell to Report Second Quarter 2024 Operating Results (GlobeNewswire) -10.58%
Jun-28-24 08:11AM	Amwell to implement reverse stock split to avoid delisting (Healthcare Dive) -13.46%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
07:00AM	Amwell Announces Reverse Stock Split (GlobeNewswire)
Jun-17-24 08:05AM	Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors (GlobeNewswire)
Jun-13-24 08:05AM	Amwell Co-Founder Roy Schoenberg Becomes Executive Vice Chairman of the Board (GlobeNewswire)
May-16-24 04:05PM	Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference (GlobeNewswire)
May-07-24 01:53PM	'Telehealth 1.0 is dead,' but don't count out digital health just yet (Yahoo Finance)
May-06-24 10:36AM	American Well Corporation (NYSE:AMWL) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 08:33AM	Q1 2024 American Well Corp Earnings Call (Thomson Reuters StreetEvents)
08:23AM	Amwell expects revenue impact from Defense contract in Q4 (Healthcare Dive)
03:51AM	American Well Corp (AMWL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
01:45AM	American Well (AMWL) Q1 2024 Earnings Call Transcript (Motley Fool)
May-01-24 07:30PM	Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics (Zacks)
06:00PM	American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
05:50PM	American Well Corp (AMWL) Q1 2024 Earnings: A Detailed Review (GuruFocus.com)
04:05PM	AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2024 (GlobeNewswire)
Apr-29-24 07:00AM	Amwell Releases 2024 Corporate Responsibility Report (GlobeNewswire) +12.92%
Apr-27-24 08:49AM	12 Most Profitable Dividend Stocks To Invest In (Insider Monkey)
Apr-25-24 07:00AM	Amwell to Participate in Upcoming Investor Conference (GlobeNewswire)
Apr-17-24 07:00AM	Amwell to Report First Quarter 2024 Operating Results May 1 (GlobeNewswire)
Apr-05-24 04:43AM	Amwell in danger of being booted from NYSE (Healthcare Dive) -10.12%
Apr-04-24 04:05PM	Amwell Receives Continued Listing Standard Notice From NYSE (GlobeNewswire) +5.41%
Mar-06-24 06:00AM	Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024 (GlobeNewswire)
Feb-23-24 05:15AM	20 Most Valuable Digital Health Companies In The US (Insider Monkey)
Feb-22-24 06:05AM	Amwell names new chief medical officer (Healthcare Dive) -6.09%
06:00AM	Amwell Names Cynthia Horner, M.D., Chief Medical Officer (GlobeNewswire)
Feb-21-24 07:00AM	Amwell Expands Presence in Australia with Amplar Health Partnership (GlobeNewswire) -8.73%
06:00AM	Amwell to Participate in Upcoming Investor Conference (GlobeNewswire)
Feb-15-24 07:00PM	American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +18.02%
02:27PM	Why American Well Corporation Stock Soared Today (Motley Fool)
10:46AM	American Well Corporation (NYSE:AMWL) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:54AM	Q4 2023 American Well Corp Earnings Call (Thomson Reuters StreetEvents)
06:00AM	Amwell Executives to Take the Stage at ViVE 2024 (GlobeNewswire)
Feb-14-24 10:00PM	American Well (AMWL) Q4 2023 Earnings Call Transcript (Motley Fool)
05:50PM	American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:14PM	Amwell Reports Fourth Quarter and Full Year 2023 Results: A Path to Profitability in Sight (GuruFocus.com)
04:05PM	Amwell Announces Results for Fourth Quarter and Full Year 2023 (GlobeNewswire)
02:22PM	Amwell cut headcount by 10% since end of 2023 (Healthcare Dive)
Jan-31-24 06:00AM	Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14 (GlobeNewswire)
Jan-18-24 08:00AM	SilverCloud by Amwell Earns Three International Awards (GlobeNewswire)

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McNeice Paul Francis	Chief Accounting Officer	Jun 02 '25	Sale	6.61	113	747	14,366	Jun 04 05:01 PM
Gotlib Phyllis	President, International	Jun 02 '25	Sale	6.61	4,782	31,628	141,849	Jun 04 05:01 PM
Phyllis Gotlib	Officer	Jun 02 '25	Proposed Sale	6.61	4,782	31,628		Jun 02 04:49 PM
Gotlib Phyllis	President, International	May 01 '25	Sale	7.21	299	2,155	146,631	May 05 04:31 PM
McNeice Paul Francis	Chief Accounting Officer	May 01 '25	Sale	7.21	8	58	14,479	May 05 04:31 PM
Phyllis Gotlib	Officer	May 01 '25	Proposed Sale	7.21	299	2,155		May 01 04:32 PM
McNeice Paul Francis	Chief Accounting Officer	Apr 01 '25	Sale	7.28	96	699	14,487	Apr 03 04:39 PM
Gotlib Phyllis	President, International	Apr 01 '25	Sale	7.28	1,068	7,775	146,930	Apr 03 04:37 PM
Phyllis Gotlib	Officer	Apr 01 '25	Proposed Sale	7.28	1,068	7,775		Apr 01 05:53 PM
McNeice Paul Francis	Chief Accounting Officer	Mar 03 '25	Sale	8.80	130	1,144	14,583	Mar 05 05:13 PM
Gotlib Phyllis	President, International	Mar 03 '25	Sale	8.80	4,781	42,061	147,998	Mar 05 05:13 PM
Vukasin Paunovich	Officer	Mar 03 '25	Proposed Sale	9.36	19,700	184,418		Mar 03 06:49 PM
Phyllis Gotlib	Officer	Mar 03 '25	Proposed Sale	9.36	5,500	51,487		Mar 03 06:48 PM
McNeice Paul Francis	Chief Accounting Officer	Feb 03 '25	Sale	10.51	9	95	9,192	Feb 05 05:34 PM
Gotlib Phyllis	President, International	Feb 03 '25	Sale	10.51	299	3,141	108,611	Feb 05 05:33 PM
Phyllis Gotlib	Officer	Feb 03 '25	Proposed Sale	10.51	299	3,141		Feb 03 04:34 PM
McNeice Paul Francis	Chief Accounting Officer	Jan 02 '25	Sale	7.17	98	703	9,201	Jan 06 04:36 PM
Gotlib Phyllis	President, International	Jan 02 '25	Sale	7.17	1,068	7,656	108,840	Jan 06 04:35 PM
Paunovich Vukasin	EVP, Enterprise Platforms	Jan 02 '25	Sale	7.17	444	3,183	116,121	Jan 06 04:30 PM
Vukasin Paunovich	Officer	Jan 02 '25	Proposed Sale	7.17	444	3,183		Jan 02 04:47 PM
Phyllis Gotlib	Officer	Jan 02 '25	Proposed Sale	7.17	1,068	7,656		Jan 02 04:47 PM
Kathy Weiler	Officer	Dec 31 '24	Proposed Sale	7.10	28,891	205,022		Dec 31 04:35 PM
Kurt Knight	Officer	Dec 31 '24	Proposed Sale	7.10	15,464	109,729		Dec 31 04:35 PM
Knight Kurt	Chief Operating Officer	Dec 02 '24	Sale	9.22	3,123	28,802	142,213	Dec 04 04:43 PM
McNeice Paul Francis	Chief Accounting Officer	Dec 02 '24	Sale	9.22	115	1,061	9,299	Dec 04 04:41 PM
Weiler Kathy Johnson	Chief Comm. & Growth Officer	Dec 02 '24	Sale	9.22	7,434	68,559	180,593	Dec 04 04:41 PM
Paunovich Vukasin	EVP, Enterprise Platforms	Dec 02 '24	Sale	9.22	3,213	29,632	116,565	Dec 04 04:41 PM
Gotlib Phyllis	President, International	Dec 02 '24	Sale	9.22	3,656	33,717	109,908	Dec 04 04:41 PM
Vukasin Paunovich	Officer	Dec 02 '24	Proposed Sale	9.22	3,213	29,632		Dec 02 04:58 PM
Kathy Weiler	Officer	Dec 02 '24	Proposed Sale	9.22	7,434	68,559		Dec 02 04:58 PM
Phyllis Gotlib	Officer	Dec 02 '24	Proposed Sale	9.22	3,656	33,717		Dec 02 04:56 PM
Kurt Knight	Officer	Dec 02 '24	Proposed Sale	9.22	3,123	28,802		Dec 02 04:56 PM
HIRSCHHORN MARK	Chief Financial Officer	Nov 05 '24	Sale	8.97	46,345	415,511	214,382	Nov 06 04:33 PM
Mark Hirschhorn	Officer	Nov 05 '24	Proposed Sale	8.97	46,345	415,511		Nov 05 04:37 PM
Knight Kurt	Chief Operating Officer	Nov 01 '24	Sale	8.93	268	2,393	145,336	Nov 05 04:36 PM
Gotlib Phyllis	President, International	Nov 01 '24	Sale	8.93	224	2,000	113,564	Nov 05 04:36 PM
McNeice Paul Francis	Chief Accounting Officer	Nov 01 '24	Sale	8.93	9	80	9,414	Nov 05 04:36 PM
Phyllis Gotlib	Officer	Nov 01 '24	Proposed Sale	8.93	224	2,000		Nov 01 05:08 PM
Kurt Knight	Officer	Nov 01 '24	Proposed Sale	8.93	268	2,393		Nov 01 05:08 PM
Paunovich Vukasin	EVP, Enterprise Platforms	Oct 01 '24	Sale	9.15	398	3,643	119,778	Oct 03 05:04 PM
Knight Kurt	Chief Operating Officer	Oct 01 '24	Sale	9.15	682	6,243	145,604	Oct 03 05:04 PM
McNeice Paul Francis	Chief Accounting Officer	Oct 01 '24	Sale	9.15	84	769	9,423	Oct 03 05:04 PM
Gotlib Phyllis	President, International	Oct 01 '24	Sale	9.15	798	7,305	113,788	Oct 03 05:03 PM
Shepardson Robert	Chief Financial Officer	Oct 01 '24	Sale	9.15	876	8,019	112,116	Oct 03 05:03 PM
Kurt Knight	Officer	Oct 01 '24	Proposed Sale	9.15	682	6,243		Oct 01 05:07 PM
Phyllis Gotlib	Officer	Oct 01 '24	Proposed Sale	9.15	798	7,305		Oct 01 05:06 PM
Robert Shepardson	Officer	Oct 01 '24	Proposed Sale	9.15	876	8,019		Oct 01 05:05 PM
Vukasin Paunovich	Officer	Oct 01 '24	Proposed Sale	9.15	398	3,643		Oct 01 05:04 PM
Shepardson Robert	Chief Financial Officer	Sep 03 '24	Sale	7.87	5,177	40,753	112,992	Sep 05 06:49 PM
Paunovich Vukasin	EVP, Enterprise Platforms	Sep 03 '24	Sale	7.87	3,141	24,726	120,176	Sep 05 06:48 PM
Weiler Kathy Johnson	Chief Comm. & Growth Officer	Sep 03 '24	Sale	7.87	7,266	57,197	188,027	Sep 05 06:48 PM
McNeice Paul Francis	Chief Accounting Officer	Sep 03 '24	Sale	7.87	165	1,299	9,507	Sep 05 06:48 PM
Gotlib Phyllis	President, International	Sep 03 '24	Sale	7.87	3,574	28,134	114,586	Sep 05 06:48 PM
Knight Kurt	Chief Operating Officer	Sep 03 '24	Sale	7.87	3,053	24,033	146,286	Sep 05 06:47 PM
Kathy Weiler	Officer	Sep 03 '24	Proposed Sale	7.87	7,266	57,197		Sep 03 06:08 PM
Vukasin Paunovich	Officer	Sep 03 '24	Proposed Sale	7.87	3,141	24,726		Sep 03 06:08 PM
Phyllis Gotlib	Officer	Sep 03 '24	Proposed Sale	7.87	3,574	28,134		Sep 03 06:07 PM
Robert Shepardson	Officer	Sep 03 '24	Proposed Sale	7.87	5,177	40,753		Sep 03 06:07 PM
Kurt Knight	Officer	Sep 03 '24	Proposed Sale	7.87	3,053	24,033		Sep 03 06:07 PM
McNeice Paul Francis	Chief Accounting Officer	Aug 01 '24	Sale	9.56	8	76	9,672	Aug 05 04:45 PM
Gotlib Phyllis	President, International	Aug 01 '24	Sale	9.56	225	2,150	118,160	Aug 05 04:43 PM
Knight Kurt	Chief Operating Officer	Aug 01 '24	Sale	9.56	268	2,561	149,339	Aug 05 04:42 PM
Kurt Knight	Officer	Aug 01 '24	Proposed Sale	9.56	268	2,561		Aug 01 05:05 PM
Phyllis Gotlib	Officer	Aug 01 '24	Proposed Sale	9.56	225	2,150		Aug 01 05:03 PM
McNeice Paul Francis	Chief Accounting Officer	Jul 01 '24	Sale	0.30	1,670	507	193,611	Jul 02 04:54 PM
Paunovich Vukasin	EVP, Enterprise Platforms	Jul 01 '24	Sale	0.30	7,956	2,415	2,461,133	Jul 02 04:54 PM
Gotlib Phyllis	President, International	Jul 01 '24	Sale	0.30	15,953	4,843	2,367,702	Jul 02 04:54 PM
Shepardson Robert	Chief Financial Officer	Jul 01 '24	Sale	0.30	17,520	5,319	2,363,399	Jul 02 04:53 PM
Knight Kurt	Chief Operating Officer	Jul 01 '24	Sale	0.30	13,636	4,140	2,992,141	Jul 02 04:53 PM
Jackson Deborah C	Director	Jun 24 '24	Sale	0.41	42,202	17,185	636,683	Jun 26 04:50 PM

AXGN

Axogen Inc

AMWL

American Well Corporation

Upgrade your FINVIZ experience